Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Wedbush Securities in New York is seeking an Equity Research Associate to join a renowned healthcare research team. You will conduct scientific and market due diligence, translate publications into investment theses, and support coverage of oncology, rare-disease, and technology platforms.
You will build and maintain financial models, interact with management, and contribute to research notes and cross-functional projects in a fast-paced environment.
We are seeking a driven Equity Research Associate to join our award-winning team of sell-side equity researchers covering the healthcare sector;, one of the most dynamic and high-impact areas intoday's capital markets.
This is a rare chance to work at the intersection of cutting-edgescience and high-stakes finance, gaining direct exposure to groundbreaking oncology, rare-disease, and platform-technologyinnovation while building the analytical toolkit of a top-tier equityresearch professional. You will work shoulder-to-shoulder with some ofthe most respected minds in the industry, with a clear runway to growyour career, your network, and your impact on how institutionalinvestors understand the future of medicine.
If you have a scientific mind, a competitive drive, and a passion forthe markets, this is your opportunity to break into, or accelerate within one of the most intellectually rewarding corners of Wall Street.
Wedbush Securities is one of the largest securities firms and investment banks in the nation. We provide innovative financial solutions through our Wealth Management, Capital Markets, Futures and Advanced Clearing & Prime Services divisions. Headquartered in Los Angeles, California with over 100 offices and more than 80 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth.
Why Join Wedbush
What You Will Do
What Wedbush Offers You
As part of our overall compensation package, Wedbush Securities offers an array of diverse benefits to all our colleagues. We believe that providing competitive benefit options yields the advantageous reward of establishing a healthy and inclusive foundational work culture.
The reasonable estimate of the compensation range for this role has not been adjusted for the applicable geographic location. A reasonable estimate of the current range is $100,000-$150,000 depending on experience. Colleagues may be eligible for additional, discretionary incentive compensation based on the colleague's and the firm's performance. At Wedbush, Decisions regarding compensation are determined on a case-by-case basis and are dependent on a variety offactors including but not limited to skill sets; experience and training; licensure and certifications; and other business and organizational needs.
Wedbush Securities (WS) is proud to be an Equal Employment Opportunity employer. WS does not discriminate based on race, religion, color, creed, sex, sexual orientation, gender, gender identity or expression, national origin, ancestry, citizenship status, registered domestic partner status, uniform service member status, marital status, pregnancy, age, medical condition, disability, genetic information, family care or medical leave status, or any other consideration made unlawful by applicable federal, state, or local laws, or on the basis that an applicant or Colleague is perceived to have these characteristics or is associated with someone who is perceived to have these characteristics. WS aims to foster a culture of inclusion where all Colleagues are valued for their unique contributions to the firm as well as provided equal opportunities to succeed.
This position is subject to various laws or regulations that impose restrictions or prohibitions for employment with Wedbush due to criminal history. Those laws or regulations include but are not limited to, the following: Securities Exchange Act of 1934 (SEA) Rule17a-3, et. seq., Financial Industry Regulatory Authority (FINRA) Rules3110(e), Rule 4530(a), etc., and FINRA Regulatory Notice 07-55.